Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.60 |
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.43 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.43 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.43 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.43 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.43 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.43 |
| ▸ | GALR3 | O60755 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22276519 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL5317764 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL151434 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| Hydrochloric Acid SCHEMBL7387030 | 0.98 | ALDH1A1 (0.58) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL8862661 | 0.87 | ALDH1A1 (0.75) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL1121858 | 0.87 | ALDH1A1 (0.75) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL853024 | 0.87 | ALDH1A1 (0.75) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL8862742 | 0.87 | ALDH1A1 (0.75) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL4394240 | 0.87 | ALDH1A1 (0.75) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL833988 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112105385-A | IRAK degrading agents and uses thereof | 凯麦拉医疗公司 | 2020-12-18 | — | — | CN | disclosed |
| EP-2119455-A1 | Tripartite raftophilic structures and their use | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2009-11-18 | — | — | EP | disclosed |
| EP-1732612-B1 | TRIPARTITE CONJUGATES CONTAINING A STRUCTURE INTERACTING WITH CELL MEMBRANE RAFTS AND THEIR USE | JADO TECHNOLOGIES GMBH (DE) | 2009-09-16 | — | — | EP | disclosed |
| US-20080317767-A1 | Tripartitle Raftophilic Strutures and their Use | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2008-12-25 | — | — | US | disclosed |
| EP-1732612-A1 | TRIPARTITE CONJUGATES CONTAINING A STRUCTURE INTERACTING WITH CELL MEMBRANE RAFTS AND THEIR USE | Jadolabs Gmbh (DE) | 2006-12-20 | — | — | EP | disclosed |
| EP-1450774-A4 | CHLORIN PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY | MIRAVANT PHARM INC (US) | 2005-10-26 | — | — | EP | disclosed |
| WO-2005097199-A1 | TRIPARTITE CONJUGATES CONTAINING A STRUCTURE INTERACTING WITH CELL MEMBRANE RAFTS AND THEIR USE | JADOLABS GMBH (DE) | 2005-10-20 | — | — | WO | disclosed |
| US-20050020559-A1 | Chlorin photosensitizing agents for use in photodynamic therapy | MIRAVANT PHARMACEUTICALS, INC., | 2005-01-27 | — | — | US | disclosed |
| EP-1450774-A2 | CHLORIN PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY | Miravant Pharmaceuticals, Inc. (US) | 2004-09-01 | — | — | EP | disclosed |
| WO-2003028629-A2 | CHLORIN PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY | MIRAVANT PHARMACEUTICALS, INC. (US) | 2003-04-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080317767-A1 | Tripartitle Raftophilic Strutures and their Use | FGB, CLTB, CD38 | ALDH1A1 245/4885TSHR 2776/4885CHRM5 2350/4885 |
| US-20050020559-A1 | Chlorin photosensitizing agents for use in photodynamic therapy | VHL, CRY1, PHLPP1 | ALDH1A1 1192/4885TSHR 3568/4885CHRM5 4587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.